CRP is the gold standard biomarker in the monitoring of inflammatory diseases, and especially in RA [10], whereas in PsA, only ~ 50% of the patients have high levels of this marker, also in the presence of active disease [36]. This evidence concerns the gene CRP and rheumatoid arthritis.